Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma

Abstract

The substantial spatial heterogeneity observed in different GBM tumor sectors, especially in spatially restricted hypermutator cases, raises important caveats to our current dependence on single-sector molecular information to guide either targeted or immune-based treatments.